chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started out I was having fevers of 101; shortness of breath; chest pain; left upper abdominal pain; I was nauseas but  not a lot; night sweats really bad; have a dry cough that I have since the second vaccine. Lymph nodes under left arm were painful for three days. Had a lot of really bad belly pain. I ended up in the hospital.  October 4th, I had my flu shot for work - I got it through medical center through my work. I still wasn't feeling well. within a couple of days. I got so sick. I had a fever; I couldn't eat (was eating baby food because it was so uncomfortable and I felt full. I went to Urgent Care on the 9th of October. They did a urine test and they said there was something going on but he sent me to ER. I went straight there. I was having left upper abdominal pain. Was hospitalized for 7 days. They don't know where the blood clot came from. I have a blood clot in my spleen that has damaged my spleen - they are looking into blood cancer or lymphoma or something. I still have a lot of pain in my abdomen.  They put me on blood thinners at the hospital. Infectious disease doctor came in and she said it looks suspicious but she said I didn't need to be on antibiotics. They sent me home with prescription for blood thinners to take. I can never take ibuprofen or anything like that again.  I still have a lot of pain and tenderness in my left upper abdomen where my spleen is. I get really tired in the evening and the afternoon. I kind of get the night sweats still but not as bad. I'm not getting fevers that I know of. I saw my regular doctor today and he explained that they don't know. Dr., Hematologist - I have to make an appt for a PET scan and then make an appt to see him. I might have to have my spleen removed. I don't know yet.
Patient presented to health dept. on 2/4/2020 for 2nd dose of Trumenba and states he had difficulty breathing about 1 hour after being vaccinated with Trumenba on 7/25/19. He said he was very ill for about 3 hours with excruciating headache as well as the difficulty breathing. Patient states symptoms eventually went away and he did not seek medical treatment. Notes on the patient's card from the administering RN show that he did pass out when he received his vaccines on 7/25/19. The health dept. was notified of this reaction on 2/4/2020 when patient presented for the 2nd dose of Trumenba. Patient was not vaccinated with the 2nd dose of Trumenba and was advised to follow up with his primary doctor should he be required to have this series for college admission.
A report has been received from a physician concerning an 8 year old, Male subject, who had been receiving Nasal FLUMIST QUADRIVALENT (Intranasal). FLUMIST QUADRIVALENT (Intranasal) started on an unknown date. The reporter stated that they accidentally gave a dose of expired FLUMIST which started on 17-Jan-2014. The outcome of the event of gave a dose of expired FLUMIST is unknown. The report was considered to be non-serious by the reporter.
COVID-19; Weakness; became sick; fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), ASTHENIA (Weakness), VACCINATION COMPLICATION (became sick) and PYREXIA (fever) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ASTHENIA (Weakness), VACCINATION COMPLICATION (became sick) and PYREXIA (fever). On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19), ASTHENIA (Weakness), VACCINATION COMPLICATION (became sick) and PYREXIA (fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Mar-2021, SARS-CoV-2 test: positive (Positive) nasal test Rapid antigen. On 30-Mar-2021, SARS-CoV-2 test: positive (Positive) Oropharyngeal RT-PCR.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported.  The patient was diagnosed with COVID-19 on 29MAR2021.  It is unknown whether the patient received the 2nd planned dose scheduled for 07APR2021.  The reporter denied any treatment.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Results of COVID-19 tests provided, symptom of fever and loss of taste for 1 day were reported
pt recv vax 26FEB97 & 1 to 2 days p/vax pt exp arthritis, arthralgias in the lt wrists, hand, arm & gen tiredness;pt was treated w/med;
Numbness right side of face; Dizziness; Numbness/tingling right side of face.; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 14Apr2021 at 14:15 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's, degenerative disc disease and raynauds, fibro. Patient had no known allergies. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) 300 mg, duloxetine hydrochloride (DULOXETINE DR) 60 mg, trazodone (MANUFACTURER UNKNOWN) 100 mg all from an unknown date from an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 15:00, the patient experienced numbness/tingling right side of face, dizziness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events numbness/tingling right side of face, dizziness was not recovered.  No follow-up attempts are needed. No further information is expected.
Pt states he has a history of fainting after I.M. Injections. Pt states he is feeling faint and wants to lay down. Pt was moved to exam area. Pts vitals are stable. Pt states he?s feeling better and would like to leave. Pt didn?t require transport to hospital.
630PM 31OCT95 pt had bumps on face similar to mosquito bite w/no other sxs;1NOV95 830AM pt noticed rash on legs;eye was swollen;mom to pt to ER;chest was beginning to tighten;given DPH & Epi & sent home;pt began itching;
Systemic: Seizure-Mild, Additional Details: AFTER 5 MINUTES OF ADMINISTARTION VACCINE PATIENT BEGIN A SEIZURE OF LESS 1 MINUTE MOTHER DESCRIBED TONIC SEIZURE PATIENT NOT HAD PAST HISTORY OF SEIZURE
Two days after receiving the booster I developed a medium sized red, very painful rash on the right side of my back at the flank area which persisted for about 3-4 days until resolving spontaneously. I did NOT have a rash anywhere else, and I did NOT have a rash with the 1st or 2nd dose of the Pfizer COVID vaccine. While I had the rash I also noticed my toes were extremely cold no matter how warm my socks were or attempts to cover them with extra blankets. The only other symptoms I had which were present for about the first two days post-vaccine were pain at the injection site (left upper arm) and fatigue. No fever. I did not take medications of any kind for the duration of my symptoms, and made sure to not take anything prior to the booster.
Pt. received DTaP, Hib, PCV13, Rotavirus. 5 minutes after receiving vaccines had a rash on face-arms-trunk-not on legs. Dr. here to check patient instructed to wait twenty minutes. Rash less, mom instructed to watch rash area.
I have had a slight headache on and off since receiving the vaccination and have taken Aspirin twice since having the vaccination 4 days ago. I can't hardly remember ever having  any headaches in many, many years or taking any medication similar to Aspirin for a headache.
mom states that between 3PM-410PM pt c/o legs itching which spread to other parts of body w/rash becoming raised (hives);pt then taken to pediatrics shortly afterward & dx of allerg rxn to vax & tx w/DPH;
The injection site was hot for a few days and I had a slight headache on 14 September at 1800 hours. 15 September 2021, every joint in my body and my lower spine ached with incredible throbbing pain.  The headaches continued the night of 15 September, and my heart felt like it was being slightly squeezed, but very noticable.   On 16 September I had numbness in my left arm and my index, middle and ring finger on my left hand were numb.  I began to feel light headed and could not regain balance if I bent over to pick something up.  The pain in my joints continued for over two weeks.  The numbness in my left arm and hand continued until 20 October 2021.  As of 29 October, all symptoms have subsided.
Chills, fever, heartburn, redness, welt and soreness at injection site.
sore throat; body aches; This is a spontaneous report from a contactable nurse received from a Pfizer-sponsored program.  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported.  The patient experienced a sore throat and body aches. The patient outcome of the events was unknown.  Information on the batch number has been requested.
Patient reported respiratory distress, onsite EMS responded. BP 180/90 HR 60 O2 99% on room air. Refused care released against medical advice.
Pt received Moderna covid 19 vaccines on Feb 6th 2021 and March 6th 2021.  She was diagnosed with new aggressive possible lymphoma or lung cancer for which she  ultimately died from on 7/2/21 . Daughters reported symptoms started suddenly 5 1/2 weeks ago around 5/20/21. PCP notes confirm this. She saw her PCP on 5/25 for the cough and a cxr done that day was normal. She was prescribed tesselon perles and azithromycin.  She presented back on 6/8 with persistent cough with new hemoptysis, decreased appetite and weight loss and ct scan done 6/15 showed a large heterogenous mass of the mediastinum 6.6 x 7.6 x 13cm encasing the r main pulmonary artery the r brachicephalic, r subclavian and common carotids. There was mass effect on the trachea and r main stem bronchus. The 6mm nodule seen in the posterior left upper lobe was stable and unchanged from previous ct chest from 9/20. This rapidly progressed in a very short time resulting in her admission to the hospital  for respiratory failure on 6/28 and she was so unstable we were unable to transfer her for a biopsy and start of treatment as recommended by oncology. She passed away on 7/2/21. The family decided they wanted to pursue a limited autopsy to have the mass biopsied to determine what the cancer was which was so rapidly progressive. They describe her as prior to the start of the cough and hemoptysis  on 5/20 that she was living alone, used no assistive devices and other than her dementia was generally healthy and was very interactive and involved with her family
mild flu-like illness; This is a spontaneous report from a contactable physician.   A 69-years-old male patient started to receive bnt162b2 (BNT162B2) intramuscular on 07Jan2021 13:00 at SINGLE DOSE for covid-19 immunisation. Medical history included hypertension and  degenerative joint disease (knees). Facility type vaccine: Hospital. vaccine location=Left arm, dose number 1. The patient's concomitant medications were not reported. The should be noted that patient had a covid-19 with an exposure date of 03Aug2020 with moderate symptoms lasting 2 weeks. The patient experienced mild flu-like illness on 08Jan2021 13:00 and lasting 20 hours with very abrupt termination of symptoms with outcome of recovered. The action taken was not applicable.  Information about lot/batch number has been requested.
an expired ipol was given to a patient with no reported adverse event; Initial information was received on 28-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 2 years old male patient who was administered an expired ipv (VERO) [Ipol] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 28-Oct-2022, the patient received ipv (VERO) standard suspension for injection at a dose of 0.25 ml once (lot TIE872M, expiry date - 10-Oct-2022) via intramuscular route in the right thigh for Immunization and patient was administered an expired ipv (VERO) with no reported adverse event (expired product administered) (latency: same day).  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
COVID 19 related hospital admission on 8/18/2021 for weakness, diarrhea, acute respiratory failure.  No admission to intensive care unit during hospitalization and no required mechanical ventilation.
2MAR91 noted the inject site itching; Below the vax site are to blisters approx 1/2 in apart 3cm in width w/fine crust area on top; no temp, no headache or malaise, no tenderness, pain, swelling or nodule formation @ vaccine site;
Received first dose of Pfizer vaccine on December 28th in left upper arm. On the afternoon of December 30th a rash was identified on my torso. It was not very itchy, took few doses of  Benadryl  and was resolved next day.  May I receive the second dose scheduled in few weeks?
Pt states shoulder looks/feels like an apple.  started late day two. It is now day three.
Patient got pale 7 minutes after the shot and it looked like he had a small seizure that lasted about 2 seconds.  His arm jerked and he dropped his phone. He never lost consciousness. I called mom who is a nurse practitioner and she said to give him juice. So I administered juice to him.  He was sitting down the whole time when he got this reaction.
02/14/2013 noticed a rapid heart beat while lying in bed.  I was not aware of adverse reactions until I looked it up online and reviewed these.  Rapid heart rate has still continued through today and I am awaiting a doctor to return my call to report this reaction.  I am unsure of the outcome as of today.
bladder infection/UTI/Antibiotics; blood in my urine; This is a spontaneous report from a contactable healthcare professional (patient). This healthcare professional reported similar events for two patients. This is the first of two reports.  A 32-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on the right arm on 13Jan2021 13:00 at a single dose for COVID-19 immunization.  The patient has no medical history. The patient's concomitant medications were not reported. The patient reported that on 27Jan2021, exactly 2 weeks after the 1st dose of the vaccine, she came down with a UTI and bladder infection which caused her to have blood in her urine. This also happened to the patient's father who suffered the same thing 2 weeks after his first vaccine. Antibiotic was given as treatment for the patient. Lab data include nasal swab COVID test: negative on 18Jan2021. The outcome of the events was recovered in 2021.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : same product and event, different patient
bronchitis; Potentially receiving the second dose of the vaccine more than 36 days after the the first dose; This spontaneous case was reported by a nurse and describes the occurrence of BRONCHITIS (bronchitis) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potentially receiving the second dose of the vaccine more than 36 days after the the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced BRONCHITIS (bronchitis) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potentially receiving the second dose of the vaccine more than 36 days after the the first dose). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, BRONCHITIS (bronchitis) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Potentially receiving the second dose of the vaccine more than 36 days after the the first dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment details included as antibiotic. No concomitant medication reported.   The patient was still on the antibiotics and will be on the prednisone for 16 days, which puts her way above the 42 days mark because she is supposed to wait 2 weeks after the prednisone before getting the second dose of the vaccine.   The patient received both scheduled doses of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event was not applicable.
A nurse reported that a 37-year-old male did not respond to the hepatitis B vaccine recombinant (Engerix-B) immunization series. The pt's medical history, concurrent conditions and concurrent medications were not reported. The pt experienced no adverse events following previous immunizations. The pt received injections of Engerix-B on 01/17/2002 (lot ENG2994C6), an unspecified date (lot ENG3231C6) and 07/25/2002 (lot ENG3231C6). Subsequently, an unspecified time post-immunization, it was determined that he had not responded to immunization. On 11/13/2002, the pt received his 4th injection of Engerix-B (lot ENG3231C6) without adverse event. On 12/11/2002, the pt received his 5th injection of Engerix-B (lot ENG3231C6) one day after the labelled expiration date. No adverse events occurred. On 01/29/2003 the pt received his 6th injection of Engerix-B (lot ENG5303A4) without adverse event.
This case was reported by a physician and described the occurrence of blister of wrist in a 25-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). The subject's medical history included reaction to vaccination. The physician reported that the subject "previously had a tetanus shot in 2002 and she got blisters on her body. They would come on different areas of her body and eventually they went away." On 22 January 2014 at 16:20 the subject received a dose of BOOSTRIX (.5 ml, unknown details, left arm). On 27 January 2014, 5 days after vaccination with BOOSTRIX, the subject experienced blister of wrist and burning sensation (forearm). Per the physician, the subject developed a blister on her right wrist. The physician reported that the subject stated "her wrist was burning and she feels that another one [blister] is coming." At the time of reporting the events were unresolved.
Began to feel soreness around entire shoulder area at 8:00 PM Monday 1/25/2021. Soreness was still there when I woke up, and the area began to itch a couple hours later. At 1:00 PM 1/26/2021 I looked at the injection site and there were raised red areas, hot to the touch, around the injection site. Not experiencing any fever or other symptoms.
Information has been received from an 18 year old female patient, for GARDASIL, a Pregnancy Registry product, with no pertinent medical history or drug allergy who in December 2011, was vaccinated with the first dose of GARDASIL (dose, frequency, route, lot # unknown). On an unspecified day the patient was vaccinated with the second dose of GARDASIL (dose, frequency, route, lot # unknown). There was no concomitant medication. The patient reported receiving her second dose of the GARDASIL series and learning afterwards that she was pregnant (reported in February 2012). She was discontinued therapy and would not receive the third dose. No AE reported. The patient sought medical attention and pregnancy test was performed. Follow up information has been unsuccessful. The pregnancy outcome lost to follow up. Additional information is not expected.
A couple of minutes after receiving all four vaccines, client stood and then half fainted into the arms of the nurse. She was immediately place in recliner chair and given juice and crackers as it was discovered she hadn't eaten anything today.
Delayed local reaction at the site of the IM injection (1 week post vaccine). The left upper arm was hot, red, swollen and painful. The area was also very itchy. The size of the affected area was about 8 cm X 6 cm.  This delayed local reaction lasted about 3 days.
Information has been received from a physician concerning a 16 year old female with no reported medical history who on 21-MAR-2008 was vaccinated with the second dose of GARDASIL (lot number not reported). There was no concomitant medication. On 21-MAR-2008 the patient experienced itchiness, bumps on her eyes, swelling and warmth at injection site. The patient was rushed to the ER on 23-MAR-2008 but not hospitalized. The patient was rushed to the ER again on 25-MAR-2008 after breaking out in hives all over her body and also not hospitalized. Subsequently, on an unspecified date the patient recovered. Additional information has been requested.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A patient of unspecified age, ethnicity and gender received TRUMENBA, via an unspecified route of administration, on an unspecified date, at single dose. Relevant medical history and concomitant  medications were not reported. The patient experienced swelling at the site of injection of TRUMENBA resulting in a lemon size lump on the patient's upper arm, on an unspecified date with outcome of unknown. Follow-up (01APR2016): Follow-up attempts are completed. No further information is expected.
Hospitalization with COVID-19 following vaccination. Admitted on 12/9/2021 with chief complaint of, "Pt tested positive for covid today, c/o SOA, worse with exertion."
Patient received moderna vaccine on 11/23/21. Presented to ER on 6/14/22 and found to be covid19 positive.
Mild/moderate nausea starting 24 hrs after vaccine, continuing for 10 hours now and has not subsided. Mild injection site soreness; Mild/moderate nausea starting 24 hrs after vaccine, continuing for 10 hours now and has not subsided. Mild injection site soreness; This is a spontaneous report from a contactable other health professional reported for herself. A 40-year-old female patient (pregnant at the time of vaccination was reported as No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on 22Dec2020 13:00, on Right arm, at single dose for COVID-19 immunization. Medical history included migraines, anxiety. Concomitant medications included fluoxetine, Vit B complex, ergocalciferol (VIT D), cetirizine hydrochloride (ZYRTEK). The patient previously took Iohexol and experienced allergies. The patient reported mild/moderate nausea starting 24 hrs after vaccine on 23Dec2020 13:00, continuing for 10 hours now and had not subsided. Also reported Mild injection site soreness on 23Dec2020 13:00. No treatment was received for the adverse events. The outcome of the events were not resolved.  Information on the lot/batch number has been requested.